Inflation Reduction Act targets Medicare drug prices, consumer costs

Inflation Reduction Act targets Medicare drug prices, consumer costs

Cancer and multiple sclerosis patients insured by Medicare are among those waiting for lower drug prices from the new Inflation Reduction Act.

Jackie Trapp has incurable blood cancer and is taking a chemotherapy drug that cost more than $240,000 last year.

Even with a Medicare drug plan, the Muskego, Wisconsin, woman said she was charged $21,740 in out-of-pocket costs for Revlimid last year. The nest egg she and her husband built has shrunk and now the couple “lives on the edge.”

Help Terms of Service Privacy Policy Your California Privacy Rights / Privacy Policy Our Ethical Principles Sitemap

© 2022 USA TODAY, a division of Gannett Satellite Information Network, LLC.

Add a Comment

Your email address will not be published.